Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use

NCT03491371 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Efficacy
Toxicity

Interventions

DRUG: Methylsulfonic apatinib

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]